Abstract To investigate the diversity of simian immunodeficiency virus (SIV) among nonhuman primates (NHPs) in Zambia, next-generation sequencing was performed to determine the complete genome sequence of a novel SIV recovered by co-culturing African green monkey (AGM) peripheral blood lymphocytes with human CD4
SIVagmTAN in C. tantalus (tantalus) and SIVagmVER in C. pygerythrus (vervet) [14] [15] [16] [17] [18] [19] [20] . To date, SIV has not been identified in rare Bale Mountains vervets (C. djamdjamensis) or malbroucks (C. cynosuros). The territorial range of malbroucks extends from the Democratic Republic of Congo to Namibia on the Atlantic coast and to Zambia in central southern Africa.
Surveillance of retroviruses in NHPs is vitally important for improving monitoring and preventing cross-species transmission of these agents. Although surveillance of simian retroviruses has been performed in a number of African countries [1] , there is no previous report of surveillance of the infection rates and diversity of simian retroviruses in Zambia, where human contact with NHPs is not uncommon. AGMs (Chlorocebus spp.) and baboons (Papio spp.) are the principal NHPs in rural and, to some extent, urban regions of Zambia, with reports of encounters leading to direct injury [21] . Therefore, we have performed surveillance of SIV from AGMs and baboons collected in Zambia.
Ethical approval was obtained from the then Zambia Wildlife Authority (ZAWA), now the Department of National Parks and Wildlife, Ministry of Tourism and Arts (certificate no. 2604). Blood and splenic tissues were isolated from AGMs (Chlorocebus sp., n = 94) and baboons (Papio sp., n = 105) in Mfuwe District in 2008/2009 as described previously [22] . The species of Zambian NHPs were identified by cytb gene sequencing as described previously [22] . Peripheral blood mononuclear cells (PBMCs) were separated by Ficoll gradient centrifugation. Genomic DNA was extracted from splenic tissue using a QIAamp DNA Isolation Kit (QIAGEN, Valencia, CA, USA), and SIV consensus PCR was performed as described [12, 23] . Total RNA was extracted from splenic tissue using an RNeasy Mini Kit (QIAGEN, Valencia, CA, USA). AGM PBMCs were stimulated with concanavalin A (10 lg/ml) for seven days in RPMI 1640 (Sigma Life Sciences, St. Louis, MO, USA) supplemented with 10% FBS at 37°C/ 5% CO 2 . AGM PBMCs were co-cultured with human MOLT-4 CD4
? T-cells in RPMI 1640 (10% FBS).
Supernatants of MOLT-4 CD4
? and M8166 CD4 ? T-cell subcultures were monitored for viral replication by reverse transcriptase colorimetric assay (Roche, Indianapolis, IN, USA) and by RT-PCR employing a Superscript III One-
Step RT-PCR System with Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA). The primers used were SIV-ZMB.F1 (5 0 -TGTACAACCCAGTCTCAGTG-3 0 ) and SIV-ZMB.R1 (5 0 -TGGAGTTATGGGGATTGCTT-3 0 ) and the thermocycling conditions were 50°C for 30 min and 94°C for 2 min; followed by 30 cycles of 94°C for 15 s, 58°C for 30 s and 72°C for 80 s.
Human MOLT-4 CD4 ? T-cell cultures persistently infected with SIVagmMAL-ZMB were ultracentrifuged at 186,000 9 g for 2 hours, and RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA, USA) with cleanup on Direct-zol RNA miniprep columns (Zymo Research, Irvine, CA, USA). cDNA synthesis was performed on 2 lg of total RNA using a Primescript cDNA synthesis kit (Takara Bio, Shiga, Japan). Library construction, emulsion PCR, enrichment and 454 sequencing (Roche, Indianapolis, IN, USA) were performed following the manufacturer's instructions. Reads were assembled using CLC Genomics Workbench software (v8.5.1, QIAGEN, Aarhus, Denmark). Rapid amplification of cDNA ends (RACE) was performed employing a SMARTer RACE cDNA amplification kit (Clontech, Mountain View, CA, USA) according to the manufacturer's instructions. SIVagmMAL-ZMB RNA was detected by real-time PCR with Fast Virus 1-Step Master Mix (Applied Biosystems, Foster City, CA, USA), 2 ll of splenic RNA extract, 400 nM SIV-ZMB(?) (
, and 100 nM SIV-ZMB probe (5 0 -FAM-ACAGCTTA-GAGAGAAAC-MGB-3 0 ) with b-actin as an internal control [24] . Thermocycling parameters were as follows: 1 cycle of 50°C for 5 min and 95°C for 20 s, followed by 40 cycles of 95°C for 3 s and 60°C for 30 s, using a StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA).
The nucleotide sequences and amino acid sequences were aligned into multiple sequence alignments by MAFFT [25] . Phylogenetic inferences were performed on multiple sequence alignments of amino acid sequences corresponding to the main proteins and nucleotide sequences of whole genomes with MrBayes 3.2 [26] , allowing for rate variations between sites modelled with a gamma distribution (?C) with five categories and percentages of invariable sites (?I).
SIV pol gene fragments were detected in 18.9% (18/95) of splenic genomic DNA samples from AGMs and 1.9% (2/105) of DNA samples from baboons by SIV consensus PCR screening. In order to isolate a replication-competent SIV from the NHPs and establish a persistently infected cell line, PBMCs (n = 50) were co-cultured with human MOLT-4 CD4
? T-cells. Expression of an SIV was examined by RT-PCR, and viral RNA was detected in human MOLT-4 and M8166 CD4
? T-cells cultured with supernatants derived from co-cultures of MOLT-4 CD4
? T-cells and PBMCs from sample ZM09-99. In addition, RT enzyme activity was present in the supernatants of infected MOLT-4 and M8166 CD4
? T-cells, with no RT activity detected in supernatants prepared from uninfected T cells. Viral cDNA prepared from supernatants from persistently infected MOLT-4 CD4
? T-cells were subjected to 454 sequencing. Genome assembly identified low-coverage regions, which were resolved by Sanger sequencing, and genomic termini were completed by RACE to obtain a SIVagm genome of 9,676 nucleotides (DDBJ accession. no. LC114462).
In order to determine the species of the NHPs examined in the present study, we sequenced the cytb genes of AGMs and baboons. This identified the AGMs as Chlorocebus cynosuros (malbrouck) on the basis of 99% nucleotide sequence identity (1139/1155 nucleotides [nt]) for the topranked hit in blastn searches and 97% identity (1116/1155 nt) to the second highest ranked hit, C. pygerythrus (vervet). The species of the baboon samples was also determined by cytb sequencing, and we found a similar degree of nucleotide sequence identity for Papio cynocephaleus (yellow baboon) and P. kindae (Kinda baboon), which are considered conspecific baboon species, both with 99% identity (1033/1034 nt) over the typing region.
The phylogenetic relationship of the complete genome of the new SIV (derived from human MOLT-4 CD4
? T-cell supernatants) to previously characterised SIV and HIV genomes is shown in Fig. 1 . On the basis of species identification of the AGMs, the malbrouck SIV was termed SIVagmMAL-ZMB and fell within the SIVagm clade and notably clustered basally to previously characterised SIVagmVER genomes and was also segregated from SIVagmSAB, SIVagmTAN and SIVagmGRI with high branching probability support. The SIVagmMAL-ZMB genome was most closely related (79% nucleotide sequence identity) to the SIVagmVER-AGM155 (GenBank accession no. M29975), which was isolated from a vervet monkey imported from Kenya [27] . To estimate phylogenetic relationships further, phylogenetic trees were constructed based on analysis of gag, pol, env and nef proteins (Fig. 2a-d) , and this also revealed tree topologies comparable to those obtained for the whole-genome nucleotide sequence analysis, with the SIVagmMAL-ZMB viral proteins branching early in the clade compared to all previously characterised Kenyan and Ethiopian vervet monkey SIVs in all phylogenies with high bootstrap support.
The SIVagmMAL-ZMB genome contains the classic gag-pol-env gene arrangement and encodes the accessory proteins vif, vpr, tat and rev, which were seen in all previously described SIVagm genomes. Comparisons of the proteins encoded in SIVagmMAL-ZMB to homologues from other SIV strains confirmed the presence of three functional motifs in the gag protein (517 aa) that are highly conserved among known primate lentiviruses in the p6 domain implicated in viral budding: L-X-X-L-F near the C-terminus of p6 gag , the dileucine motif D-X-A-X-X-L-L previously found to be associated with vpr in SIVagm, and the highly conserved lentivirus motif P-T/S-A-P were present in SIVagmMAL-ZMB as L-N-S-L-F, D-P-A-K-K-L-L and P-S-A-P, respectively. The SIVagmMAL-ZMB env protein (876 aa) contains 18 highly conserved cysteine residues that are present in all SIVs and six additional Fig. 1 Phylogenetic tree based on the SIVagmMAL-ZMB genome sequence and representative SIV genome sequences. The probability of the branching is shown next to the nodes. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The scale bar represents a distance of 0.1 substitutions per site. SIVagmMAL-ZMB is indicated cysteine residues that are conserved in the group including SIVagmSAB, SIVagmTAN and SIVagmGRI [13] . The cellular tropism of SIV is largely determined by the env gp120 V3 loop, which is 34 amino acids long in SIVagmMAL-ZMB, with the crown consisting of the motif M-A-G, as seen in previously described SIVagm strains [28] . It should be noted that the SIVagmMAL-ZMB genome was obtained following propagation in MOLT-4 CD4
? T cells and may contain mutations for adaptation to growth in human T cells. Therefore, the V3 loop of the gp120 region was amplified from splenic genomic DNA from sample ZM09-99 and sequenced, and the sequence was compared to the corresponding region of SIVagm-MAL-ZMB obtained after T-cell culture. No mutations were detected over the 34 amino acids when the two samples were compared.
To evaluate RNA integrity in NHP spleen extracts, bactin was examined in samples from each species that yielded overlapping ranges and comparable mean Ct val- Surveillance of retroviruses in NHPs in several African countries has been performed; however, no surveillance from Zambia has been reported previously. Studies of SIV seroprevalence in baboons from Tanzania (P. ursinus) indicated low levels (\1%) of antibody positivity to SIV [29] , indicative of low levels of SIV infection in this species. A recent study of AGM populations in the wild examined C. sabaeus from Gambia in West Africa and found high SIV seroprevalence (44%) [30] . In a study in South Africa, SIV seroprevalence in vervet monkeys varied considerably between infants/juveniles (7%) and adults (68%) and between adult females (78%) and males (57%) [31] . This variation in seroprevalence rates between AGMs and baboons was also observed in a study of 11 NHP species in Cameroon, which gave reactivity rates of 0-52%, reflecting host-, gender-and age-specific differences in susceptibility to infection [32] .
Development of non-invasive sampling methods for the characterisation of SIV in faecal and urine samples has stimulated studies of the natural history of SIV of endangered species such as chimpanzees, gorillas and bonobos [1] . The blood and splenic tissue samples collected from AGMs and baboons in the present study were collected in 2008 and 2009 prior to the advent of these non-invasive sampling methodologies. These non-invasive sampling approaches have greatly boosted studies on health and long-term survival by allowing the simian faecal virome to be analysed [1] . Further studies in Zambia will focus on the development of these non-invasive sampling approaches to study the natural history of simian retroviruses in NHPs.
Ayouba and colleagues have highlighted that despite the fact that the six AGM species proposed by Groves [33] represent an important potential zoonotic reservoir of simian retroviruses for spillover into human populations, only eight complete genome sequences have been annotated: C. pygerythrus (vervet, n = 4), C. sabaeus (green monkey, n = 2), C. tantalus (tantalus monkey, n = 1), C. aethiops (grivet, n = 1), C. djamdjamensis (Bale Mountains vervet, n = 0) and C. cynosuros (malbrouck, n = 0) [19] . Given the broad distribution of AGMs across Africa, this study is the first to report an SIV genome from the malbrouck monkey. Our results may serve to improve our understanding of the evolutionary history of SIV in NHPs. Further studies are required to examine the prevalence of the newly described SIV in malbrouck, vervet, and other AGM and NHP species elsewhere in Africa, the natural history of the agent, whether it has an impact on fitness, and what evidence exists, by use of specific serological assays, of exposure in human populations.
